** Genetic testing firm Natera's NTRA.O shares rise 17.9%
to $159
** Co late on Tuesday forecast annual revenue between $1.61
bln and $1.64 bln, higher than previous estimate of $1.49 bln to
$1.52 bln
** At least 9 brokerages raise PT
** Brokerage BTIG raises PT to $185 from $150, says, "Natera
knocks it out of the park, again - fundamentals of the business
keep improving"
** Co reported Q3 rev of $439.8 mln compared with $268.3 mln
a year ago — an increase of 63.9%
** NTRA says increase in total revenues driven by 64.4%
increase in product revenues, which were $436.1 mln in Q3 vs
$265.2 mln a year ago
** Processed about 775,800 tests in Q3, compared with about
626,000 tests a year ago - NTRA
** Including session's moves, stock more than doubled YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))